- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03918785
Rice Germ Supplementation on Swimmers (RGS swimmers)
Rice Germ Supplementation on Moderately Trained Swimmers: a Randomized Pilot Clinical Trial
In order to enhance the effects of training and improve performance, athletes often turn to nutritional supplements. According to the American College of Sports Medicine (ACSM), adequate selection of nutrients and supplements, adjusting intake according to the exercise performed, is necessary for optimal performance in athletes. The most recent consensus from the International Society for Sport Nutrition (ISSN), The American Dietetic Association (ADA) and ACSM on sport nutrition have been reviewed by Potgieter, stating that a single guideline is not sufficient to elaborate an individualized and focused nutritional management of athletes. Moreover, apart from the abovementioned guidelines, sport-specific nutritional strategies, including quantity, structure and timing of food (or supplement) intake should also be followed in order to maximize sports performance and recovery. The importance of dietary supplementation is of particular interest in swimming, where athletes usually undertake a training approach characterized by a high volume of training during aerobic development and high intensity training during the competition phase, coupled with strength training.
The size and market value of the sports supplement industry is continuing to grow, with health, safety and contamination concerns becoming more pressing. Therefore, it is important to identify dietary supplements that are safe and effective in supporting swimmers. Rice germ could be a safe and effective dietary supplement for swimmers. In the last few years, scientific research is trying to use waste rice products in the pharmaceutical and nutraceutical fields, considering the potential value of nutrients they contain. In particular, rice germ has a high protein and essential amino acids, such as lysine, histidine and valine content, a good lipid content (with prevalence of mono- unsaturated and polyunsaturated fatty acids - in particular linoleic and linolenic essential fatty acids and oleic acid), an high fiber presence; regarding water-soluble vitamins, rice germ has high content if thiamine (B1) and pyridoxine (B6), while vitamin E prevails for liposoluble vitamins. About minerals, are most present iron and magnesium. All these nutrients play important roles in maintaining the health of athletes. Currently, despite these characteristics, no study has evaluated the potential beneficial effect of RG supplementation on athletes. Given this background, the purpose of this investigation was to ascertain whether performance in swimmers could be improved by a 5-weeks of RG supplementation.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- moderately trained athletes
- regularly involved in regional and national competitions
Exclusion Criteria:
- No history of cardiac or respiratory disease
- no medication at the time of the study
- no abnormalities on physical examination or on resting electrocardiogram
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Rice Germ
The Rice Germ was supplied in vacuum jars of a weight of 130 grams.
These jars once opened, were stored in the refrigerator (-3-4°C).
Together with cans, small containers were provided to act as dosers and served to determine the correct dose to be taken (25 grams, twice a day).
The rice germ or placebo were continually taken every day twice a day (25 grams in the morning with breakfast and 25 grams in the afternoon as snacks) for 5 weeks.
The rice germ was supplied by the company "Acquerello" (TenutaColombara, Livorno Ferraris, Vercelli, Italy).
|
25 g twice a day.
|
Active Comparator: Control group
Active comparator, which consisted of an isocaloric wheat germ-based supplement.
Characteristics of supplementation are the same of experimental group.
|
25g twice a day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Performance change
Time Frame: At baseline and after 5 weeks of supplementation
|
Whether the performance in 50m, 200m, is improved in a 25m swimming pool in front crawl at maximal speed.
Performance measured in seconds.
|
At baseline and after 5 weeks of supplementation
|
Lactic acid production change
Time Frame: At baseline and after 5 weeks
|
Capillary blood samples were collected from the fingertip before and after each swimming (at the 1st and 3rdmin of recovery) to access the higher values of blood lactate concentration (AccutrendLactate®Roche, Germany).
|
At baseline and after 5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Antropometric measures change (skinfolds)
Time Frame: At baseline and after 5 weeks of supplementation
|
skinfolds thicknesses (mm) (biceps, triceps, suprailiac, subscapular), measured twice using a Harpenden skinfold caliper at 5 min intervals at each site
|
At baseline and after 5 weeks of supplementation
|
Body weight change (kg)
Time Frame: At baseline and after 5 weeks of supplementation
|
Change in body weight (kg).
|
At baseline and after 5 weeks of supplementation
|
Antropometric measures change (circumferences)
Time Frame: At baseline and after 5 weeks of supplementation
|
Waist circumference (cm), hip circumference (cm), mid-arm circumference (cm).
|
At baseline and after 5 weeks of supplementation
|
Change in Total fat mass, total free fat mass and visceral adipose tissue (DXA)
Time Frame: At baseline and after 5-weeks of supplementation
|
Body composition by dual-energy X-ray absorptiometry (DXA).
Body composition was measured at baseline by DXA, using a Lunar Prodigy DEXA (GE Medical Systems, Waukesha, WI).
Free Fat mass, Fat mass and visceral fat (kg) data were derived from DXA using the DXA Prodigy enCORE software (version 17; GE Healthcare).
|
At baseline and after 5-weeks of supplementation
|
Body composition parameters change (BIVA)
Time Frame: At baseline and after 5-weeks of supplementation
|
Body composition analyzed with BIVA: free fat mass, fat mass, body cellular mass change (kg).
|
At baseline and after 5-weeks of supplementation
|
Hydration parameters change (BIVA)
Time Frame: At baseline and after 5-weeks of supplementation
|
Hydration analyzed with BIVA: total body water, extracellular water, intracellular water change (L)
|
At baseline and after 5-weeks of supplementation
|
Registration of adverse effects
Time Frame: After 7 days, 14 days, 21 days, 28 days from baseline and after 5 weeks.
|
Adverse effects recorded, through phone call
|
After 7 days, 14 days, 21 days, 28 days from baseline and after 5 weeks.
|
Muscle function change
Time Frame: At baseine and after 5 weeks.
|
The JAMAR Hand Dynamometer (Jamar 5030J1; Sammons Preston Rolyan; accuracy 0.6 N) was used to assess muscle function with the use of a standardized procedure(Spijkerman, Dorine C., Snijders, Chris J., Stijnen, Theo, & Lankhorst 1991).
Handgrip measured in kilograms.
|
At baseine and after 5 weeks.
|
Collaborators and Investigators
Investigators
- Study Director: Mariangela Rondanelli, MD, PhD, Professor, Mariangela Rondanelli, IRCCS Mondino Foundation, Pavia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1114/06072014
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Athletes
-
PepsiCo Global R&DCompletedFluid Intake in Athletes | Sweating Rate in Athletes | Sweat Chloride Concentration in AthletesUnited States
-
University of BrasiliaNot yet recruiting
-
Universiti Putra MalaysiaNot yet recruiting
-
Hong Kong Metropolitan UniversityCompleted
-
São Paulo State UniversityCompleted
-
Dokuz Eylul UniversityRecruitingAthletes | VolleyballTurkey
-
Investigación en Hemofilia y FisioterapiaCompleted
-
Istituto per la Ricerca e l'Innovazione BiomedicaCompleted
-
Ellen Cristini de FreitasCitrosuco CompanyCompleted
Clinical Trials on Rice germ
-
Azienda di Servizi alla Persona di PaviaCompleted
-
Universidade do PortoCenter for Health Technology and Services Research; Project VALORINTEGRADOR...CompletedHealthy VolunteersPortugal
-
University of Santo TomasEnrolling by invitationDyslipidemias | Overweight or Obesity | Hyperglycaemia (Non Diabetic)Philippines
-
University of ManitobaMitacsCompleted
-
Clinical Nutrition Research Centre, SingaporeCompletedMetabolic Diseases
-
Chinese Academy of SciencesHarvard School of Public Health (HSPH)Completed
-
University of MinnesotaCompleted
-
Tufts UniversityCompleted
-
Harvard School of Public Health (HSPH)Madras Diabetes Research FoundationCompletedDiabetes MellitusIndia
-
Purdue UniversityCompletedAppetitive Behavior